|
McEwan P, Harrison C, Binnie R, Lewis RD, Cohen-Solal A, Lund LH, Ohlsson M, von Haehling S, Comin-Colet J, Pascual-Figal DA, Wachter S, Dorigotti F, de Arellano AR, Ponikowski P, Jankowska EA. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation. Eur J Heart Fail. 2023 Mar;25(3):389-398. doi: 10.1002/ejhf.2788. Epub 2023 Mar 7. PubMed PMID: 36718652.
AÑO: 2023; IF: 16.9
|
|
Amiguet M, Palau P, Dominguez E, Seller J, Pinilla JMG, de la Espriella R, Minana G, Valle A, Sanchis J, Gorriz JL, Bayes-Genis A; DAPA VO2 investigators; Nunez J. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction. Sci Rep. 2023 Jun 30;13(1):10591. doi: 10.1038/s41598-023-37491-5. PubMed PMID: 37391470; PubMed Central PMCID: PMC10313805.
AÑO: 2023; IF: 3.8
|
|
Diez-Diez M, Amoros-Perez M, de la Barrera J, Vazquez E, Quintas A, Pascual-Figal DA, Dopazo A, Sanchez-Cabo F, Kleinman ME, Gordon LB, Fuster V, Andres V, Fuster JJ. Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. Geroscience. 2023 Apr;45(2):1231-1236. doi: 10.1007/s11357-022-00607-2. Epub 2022 Jun 25. PubMed PMID: 35752705; PubMed Central PMCID: PMC9886702.
AÑO: 2023; IF: 5.4
|
|
Pascual-Figal D, Fuster JJ, Bayes-Genis A. Personalizing anti-inflammatory therapy in heart failure: A new way. Eur J Heart Fail. 2023 Nov;25(11):1933-1935. doi: 10.1002/ejhf.3052. Epub 2023 Oct 17. No abstract available. PubMed PMID: 37792725.
AÑO: 2023; IF: 16.9
|
|
Escobar C., Pascual-Figal D., Manzano L., Nuñez J., Camafort M. Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin. Journal of Clinical Medicine. November 2023. 12. 10.3390/jcm12216798
AÑO: 2023; IF: 3.0
|